JP2020203894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020203894A5 JP2020203894A5 JP2020135954A JP2020135954A JP2020203894A5 JP 2020203894 A5 JP2020203894 A5 JP 2020203894A5 JP 2020135954 A JP2020135954 A JP 2020135954A JP 2020135954 A JP2020135954 A JP 2020135954A JP 2020203894 A5 JP2020203894 A5 JP 2020203894A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- cardiac
- deletion
- seq
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022178566A JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13151593 | 2013-01-17 | ||
| EP13151593.4 | 2013-01-17 | ||
| JP2015553072A JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Division JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178566A Division JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020203894A JP2020203894A (ja) | 2020-12-24 |
| JP2020203894A5 true JP2020203894A5 (https=) | 2025-02-04 |
| JP7685737B2 JP7685737B2 (ja) | 2025-05-30 |
Family
ID=47559322
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Active JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2020135954A Active JP7685737B2 (ja) | 2013-01-17 | 2020-08-11 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2022178566A Pending JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A Pending JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Active JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178566A Pending JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A Pending JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10369198B2 (https=) |
| EP (2) | EP3747457A3 (https=) |
| JP (4) | JP6809789B2 (https=) |
| CN (6) | CN111100197B (https=) |
| CA (1) | CA2898128A1 (https=) |
| DK (1) | DK2945642T3 (https=) |
| ES (1) | ES2986021T3 (https=) |
| FI (1) | FI2945642T3 (https=) |
| HR (1) | HRP20240623T1 (https=) |
| HU (1) | HUE068364T2 (https=) |
| LT (1) | LT2945642T (https=) |
| PL (1) | PL2945642T3 (https=) |
| PT (1) | PT2945642T (https=) |
| RS (1) | RS65553B1 (https=) |
| SI (1) | SI2945642T1 (https=) |
| WO (1) | WO2014111458A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3747457A3 (en) * | 2013-01-17 | 2021-03-03 | Medizinische Hochschule Hannover | Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases |
| ES2902533T3 (es) | 2013-11-21 | 2022-03-28 | Brigham & Womens Hospital Inc | Composiciones y métodos para tratar la hipertensión pulmonar |
| EP3174550B1 (en) * | 2014-08-01 | 2020-01-29 | The Brigham and Women's Hospital, Inc. | Methods and compositions relating to treatment of pulmonary arterial hypertension |
| US10435757B1 (en) | 2016-06-15 | 2019-10-08 | University Of South Florida | Methods of measuring C19MC miRNA in a post-natal tissue and uses thereof |
| CN108802372B (zh) * | 2018-06-19 | 2021-05-11 | 上海伦泽生物科技有限公司 | 检测人血清中内质网膜蛋白复合体亚单位10的试剂盒 |
| EP4087489B1 (en) | 2020-01-08 | 2025-05-14 | Vitruvia Holdings Inc. | Methods and computing system for processing ultrasound image to determine health of subdermal tissue |
| MX2022008727A (es) * | 2020-01-21 | 2022-10-07 | Boehringer Ingelheim Int | Factor de crecimiento derivado de mieloide para su uso en el tratamiento o la prevencion de fibrosis, hipertrofia o insuficiencia cardiaca. |
| CN114149500B (zh) * | 2020-09-07 | 2023-12-01 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体在制备治疗和/或预防脂肪肝的产品中的应用 |
| CN114149499B (zh) * | 2020-09-07 | 2023-12-05 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体及其在治疗和/或预防肥胖症中的应用 |
| CN114149498B (zh) * | 2020-09-07 | 2023-12-05 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体在防治2型糖尿病中的应用 |
| JP2024501821A (ja) | 2020-12-23 | 2024-01-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 心臓組織細胞に対する特異性を有するウイルスカプシドタンパク質 |
| KR20240032971A (ko) * | 2021-07-08 | 2024-03-12 | 테나야 테라퓨틱스, 인코포레이티드 | 유전자 요법을 위한 최적화된 발현 카세트 |
| CA3258215A1 (en) | 2022-06-03 | 2023-12-07 | Boehringer Ingelheim International Gmbh | RECOMBINANT EXPRESSION OF THE MYELOID-DERIVED GROWTH FACTOR |
| CN120112304A (zh) | 2022-09-08 | 2025-06-06 | 勃林格殷格翰国际有限公司 | 用于治疗心源性休克的髓源性生长因子 |
| WO2025047991A1 (en) | 2023-09-01 | 2025-03-06 | Boehringer Ingelheim International Gmbh | Myeloid-derived growth factor for use in treating or preventing a liver disorder |
| WO2025073372A1 (en) | 2023-10-05 | 2025-04-10 | Boehringer Ingelheim International Gmbh | Recombinant expression of myeloid-derived growth factor |
| WO2025120204A1 (en) | 2023-12-06 | 2025-06-12 | Boehringer Ingelheim International Gmbh | Novel formulation comprising myeloid-derived growth factor |
| CN120738287B (zh) * | 2025-07-03 | 2026-02-24 | 广州医科大学附属妇女儿童医疗中心 | 急性低灌注动物模型的构建方法及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| WO1997047358A1 (en) | 1996-06-11 | 1997-12-18 | Merck & Co., Inc. | Synthetic hepatitis c genes |
| JP2001506484A (ja) * | 1996-09-13 | 2001-05-22 | 財団法人相模中央化学研究所 | 分泌シグナル配列を有するヒト蛋白質およびそれをコードするｄｎａ |
| AU4220797A (en) * | 1996-09-13 | 1998-04-02 | Protegene Inc. | Human proteins having secretory signal sequences and DNAs encoding these prot eins |
| WO2002008284A2 (en) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| AU745409B2 (en) * | 1997-01-29 | 2002-03-21 | Cornell Research Foundation Inc. | Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| US6794144B1 (en) | 1999-05-26 | 2004-09-21 | Licentia Ltd. | Methods and materials for generating SH3 domains with tailored binding properties |
| EP1212417B1 (en) * | 1999-06-02 | 2008-04-30 | Genentech Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
| WO2001012669A1 (en) | 1999-08-16 | 2001-02-22 | Universita' Degli Studi Di Siena | Vegf-d and angiogenic use thereof |
| WO2002081681A1 (fr) * | 2001-03-30 | 2002-10-17 | Chugai Seiyaku Kabushiki Kaisha | Nouvelle utilisation de la cytokine sf20 |
| DE10119804A1 (de) * | 2001-04-23 | 2002-10-24 | Brahms Ag | Entzündungsspezifische Peptide und deren Verwendungen |
| US7452968B2 (en) * | 2003-01-02 | 2008-11-18 | University Of Southern California | Secreted protein factor and cell membrane-bound splice variant |
| WO2004069173A2 (en) * | 2003-01-31 | 2004-08-19 | The Trustees Of The University Of Pennsylvania | Methods for modulating an inflammatory response |
| WO2005074836A1 (en) | 2004-01-29 | 2005-08-18 | Brown University | Methods for progenitor cell recruitment and isolation |
| CN101160055A (zh) * | 2005-02-16 | 2008-04-09 | 莱蒂恩公司 | 慢病毒载体及其用途 |
| US20080004232A1 (en) * | 2006-05-09 | 2008-01-03 | John Wilkins | Characterization of c19orf10, a Novel Synovial Protein |
| EP1892248A1 (en) | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| EP2130547A1 (en) * | 2008-06-06 | 2009-12-09 | Giuliani International Limited | IL-25 for use in the treatment of inflammatory diseases |
| BR112012004546A8 (pt) * | 2009-08-29 | 2017-12-05 | Abbott Lab | Terapêutica por proteínas ligantes dll4-ligantes |
| US8735342B2 (en) | 2010-01-27 | 2014-05-27 | Neumedicines, Inc. | Method for treating brain cancer using a novel tumor suppressor gene and secreted factor |
| KR20120095063A (ko) * | 2011-02-18 | 2012-08-28 | 가톨릭대학교 산학협력단 | ＩＬ-27로 유도된 ｐ53을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 |
| EP3747457A3 (en) * | 2013-01-17 | 2021-03-03 | Medizinische Hochschule Hannover | Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases |
-
2014
- 2014-01-16 EP EP20178045.9A patent/EP3747457A3/en not_active Ceased
- 2014-01-16 PL PL14700872.6T patent/PL2945642T3/pl unknown
- 2014-01-16 US US14/759,852 patent/US10369198B2/en active Active
- 2014-01-16 FI FIEP14700872.6T patent/FI2945642T3/fi active
- 2014-01-16 CN CN201911137853.9A patent/CN111100197B/zh active Active
- 2014-01-16 HU HUE14700872A patent/HUE068364T2/hu unknown
- 2014-01-16 EP EP14700872.6A patent/EP2945642B1/en active Active
- 2014-01-16 HR HRP20240623TT patent/HRP20240623T1/hr unknown
- 2014-01-16 CA CA2898128A patent/CA2898128A1/en active Pending
- 2014-01-16 CN CN201911137854.3A patent/CN110922468B/zh active Active
- 2014-01-16 CN CN201480005079.5A patent/CN104968361B/zh active Active
- 2014-01-16 SI SI201432073T patent/SI2945642T1/sl unknown
- 2014-01-16 WO PCT/EP2014/050788 patent/WO2014111458A2/en not_active Ceased
- 2014-01-16 CN CN201911124174.8A patent/CN110894226A/zh active Pending
- 2014-01-16 JP JP2015553072A patent/JP6809789B2/ja active Active
- 2014-01-16 PT PT147008726T patent/PT2945642T/pt unknown
- 2014-01-16 RS RS20240548A patent/RS65553B1/sr unknown
- 2014-01-16 CN CN201911138039.9A patent/CN110922467A/zh active Pending
- 2014-01-16 CN CN201911137855.8A patent/CN110903378A/zh active Pending
- 2014-01-16 LT LTEPPCT/EP2014/050788T patent/LT2945642T/lt unknown
- 2014-01-16 ES ES14700872T patent/ES2986021T3/es active Active
- 2014-01-16 DK DK14700872.6T patent/DK2945642T3/da active
-
2020
- 2020-08-11 JP JP2020135954A patent/JP7685737B2/ja active Active
-
2022
- 2022-11-08 JP JP2022178566A patent/JP2023025005A/ja active Pending
-
2025
- 2025-06-03 JP JP2025092726A patent/JP2025143268A/ja active Pending